Abstract
Metabolic syndrome (MetS) is associated with additional cardiovascular risk in mammalians while there are relationships between hyperglycemia-associated cardiovascular dysfunction and increased platelet P2Y12 receptor activation. Although P2Y12 receptor antagonist ticagrelor (Tica) plays roles in reduction of cardiovascular events, its beneficial mechanism remains poorly understood. Therefore, we aimed to clarify whether Tica can exert a direct protective effect in ventricular cardiomyocytes from high-carbohydrate diet-induced MetS rats, at least, through affecting sarcoplasmic reticulum (SR)–mitochondria (Mit) miscommunication. Tica treatment of MetS rats (150 mg/kg/day for 15 days) significantly reversed the altered parameters of action potentials by reversing sarcolemmal ionic currents carried by voltage-dependent Na+ and K+ channels, and Na+/Ca2+-exchanger in the cells, expressed P2Y12 receptors. The increased basal-cytosolic Ca2+ level and depressed SR Ca2+ load were also reversed in Tica-treated cells, at most, though recoveries in the phosphorylation levels of ryanodine receptors and phospholamban. Moreover, there were marked recoveries in Mit structure and function (including increases in both autophagosomes and fragmentations) together with recoveries in Mit proteins and the factors associated with Ca2+ transfer between SR–Mit. There were further significant recoveries in markers of both ER stress and oxidative stress. Taken into consideration the Tica-induced prevention of ER stress and mitochondrial dysfunction, our data provided an important document on the pleiotropic effects of Tica in the electrical activity of the cardiomyocytes from MetS rats. This protective effect seems through recoveries in SR–Mit miscommunication besides modulation of different sarcolemmal ion-channel activities, independent of P2Y12 receptor antagonism.
Similar content being viewed by others
Data availability
The data used to support the findings of this study are available from the corresponding author upon reasonable request.
References
Kahn R (2005) Buse J Ferrannini E y cols. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and European Association for the Study of Diabetes. Diabetes Care 28:2289–2304
Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH (2008) The metabolic syndrome. Endocr Rev 29:777–822
Abel ED, Litwin SE, Sweeney G (2008) Cardiac remodeling in obesity. Physiol Rev 88:389–419
Durak A, Olgar Y, Tuncay E, Karaomerlioglu I, Kayki Mutlu G, Arioglu Inan E, Altan VM, Turan B (2017) Onset of decreased heart work is correlated with increased heart rate and shortened QT interval in high-carbohydrate fed overweight rats. Can J Physiol Pharmacol 95:1335–1342
Durak A, Olgar Y, Degirmenci S, Akkus E, Tuncay E, Turan B (2018) A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats. Cardiovasc Diabetol 17:1–17
Olgar Y, Tuncay E, Billur D, Durak A, Ozdemir S, Turan B (2020) Ticagrelor reverses the mitochondrial dysfunction through preventing accumulated autophagosomes-dependent apoptosis and ER stress in insulin-resistant H9c2 myocytes. Molecular and Cellular Biochemistry. https://doi.org/10.1007/s11010-020-03731-9
Hollopeter G, Jantzen H-M, Vincent D, Li G, England L, Ramakrishnan V, Yang R-B, Nurden P, Nurden A, Julius D (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202–207
Simon J, Filippov AK, Göransson S, Wong YH, Frelin C, Michel AD, Brown DA, Barnard EA (2002) Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277:31390–31400. https://doi.org/10.1074/jbc.M110714200
Wihlborg A-K, Wang L, Braun OO, Eyjolfsson A, Gustafsson R, Gudbjartsson T, Erlinge D (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24:1810–1815
Kawaguchi A, Sato M, Kimura M, Ichinohe T, Tazaki M, Shibukawa Y (2015) Expression and function of purinergic P2Y12 receptors in rat trigeminal ganglion neurons. Neurosci Res 98:17–27. https://doi.org/10.1016/j.neures.2015.04.008
Sasaki Y, Hoshi M, Akazawa C, Nakamura Y, Tsuzuki H, Inoue K, Kohsaka S (2003) Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain. Glia 44:242–250. https://doi.org/10.1002/glia.10293
Gachet C (2012) P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signal 8:609–619. https://doi.org/10.1007/s11302-012-9303-x
Yang H, Tang B, Xu CH, Ahmed A (2019) Ticagrelor versus prasugrel for the treatment of patients with Type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis. Diabetes Therapy 10:81–93
Åkerblom A, Wojdyla DM, Wallentin L, James SK, de Souza BF, Steg PG, Cannon CP, Katus HA, Himmelmann A, Storey RF (2019) Ticagrelor in patients with heart failure after acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J 213:57–65
Sweeny JM, Angiolillo DJ, Franchi F, Rollini F, Waksman R, Raveendran G, Dangas G, Khan ND, Carlson GF, Zhao Y (2017) Impact of diabetes mellitus on the pharmacodynamic effects of ticagrelor versus clopidogrel in troponin-negative acute coronary syndrome patients undergoing ad hoc percutaneous coronary intervention. Journal of the American Heart Association 6:e005650
Franchi F, Rollini F, Aggarwal N, Hu J, Kureti M, Durairaj A, Duarte VE, Cho JR, Been L, Zenni MM (2016) Pharmacodynamic comparison of prasugrel versus ticagrelor in patients with type 2 diabetes mellitus and coronary artery disease: the OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 study. Circulation 134:780–792
Mansour A, Bachelot-Loza C, Nesseler N, Gaussem P, Gouin-Thibault I (2020) P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation. Int J Mol Sci 21:1391
Nylander S, Schulz R (2016) Effects of P2Y12 receptor antagonists beyond platelet inhibition–comparison of ticagrelor with thienopyridines. Br J Pharmacol 173:1163–1178
Schnorbus B, Daiber A, Jurk K, Warnke S, König J, Krahn U, Lackner K, Munzel T, Gori T (2014) Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study. BMJ open. https://doi.org/10.1136/bmjopen-2014-005268
Serebruany VL, Atar D (2010) The PLATO trial: do you believe in magic? Oxford University Press
Audia JP, Yang X-M, Crockett ES, Housley N, Haq EU, O’Donnell K, Cohen MV, Downey JM, Alvarez DF (2018) Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y 12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol 113:32
Tubbs E, Rieusset J (2017) Metabolic signaling functions of ER–mitochondria contact sites: role in metabolic diseases. J Mol Endocrinol 58:R87–R106
López-Crisosto C, Bravo-Sagua R, Rodriguez-Peña M, Mera C, Castro PF, Quest AF, Rothermel BA, Cifuentes M, Lavandero S (2015) ER-to-mitochondria miscommunication and metabolic diseases. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852:2096–2105
Missiroli S, Danese A, Iannitti T, Patergnani S, Perrone M, Previati M, Giorgi C, Pinton P (2017) Endoplasmic reticulum-mitochondria Ca2+ crosstalk in the control of the tumor cell fate. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1864:858–864
Pinton P, Giorgi C, Pandolfi P (2011) The role of PML in the control of apoptotic cell fate: a new key player at ER–mitochondria sites. Cell Death Differ 18:1450–1456
Gale EA (2005) The myth of the metabolic syndrome. Springer
Huang B, Qian Y, Xie S, Ye X, Chen H, Chen Z, Zhang L, Xu J, Hu H, Ma S (2020) Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y 12 signaling pathway. Cellular & Molecular Immunology 18:1278–1289
Penna C, Aragno M, Cento AS, Femminò S, Russo I, Bello FD, Chiazza F, Collotta D, Alves GF, Bertinaria M (2020) Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2020/9219825
Cheng L, Fu H, Wang X, Ye L, Lakhani I, Tse G, Zhang Z, Liu T, Li G (2020) Effects of ticagrelor pretreatment on electrophysiological properties of stellate ganglion neurons following myocardial infarction. Clin Exp Pharmacol Physiol 47:1932–1942
Sebastián D, Hernández-Alvarez MI, Segalés J, Sorianello E, Muñoz JP, Sala D, Waget A, Liesa M, Paz JC, Gopalacharyulu P (2012) Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci 109:5523–5528
Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285. https://doi.org/10.1016/j.clinbiochem.2003.11.015
Turan B, Desilets M, Acan LN, Hotomaroglu O, Vannier C, Vassort G (1996) Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc Res 32:351–361
Tuncay E, Olgar Y, Durak A, Degirmenci S, Bitirim CV, Turan B (2019) β3-adrenergic receptor activation plays an important role in the depressed myocardial contractility via both elevated levels of cellular free Zn2+ and reactive nitrogen species. J Cell Physiol 234:13370–13386
Durak A, Bitirim CV, Turan B (2020) Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats. Cardiovascular drugs and therapy. https://doi.org/10.1007/s10557-020-06974-2
Ozdemir S, Ugur M, Gürdal H, Turan B (2005) Treatment with AT1 receptor blocker restores diabetes-induced alterations in intracellular Ca2+ transients and contractile function of rat myocardium. Arch Biochem Biophys 435:166–174
Bilginoglu A, Kandilci HB, Turan B (2013) Intracellular levels of Na+ and TTX-sensitive Na+ channel current in diabetic rat ventricular cardiomyocytes. Cardiovasc Toxicol 13:138–147
Lariccia V, Macrì ML, Matteucci A, Maiolino M, Amoroso S, Magi S (2019) Effects of ticagrelor on the sodium/calcium exchanger 1 (NCX1) in cardiac derived H9c2 cells. Eur J Pharmacol 850:158–166
Rossini M, Filadi R (2020) Sarcoplasmic Reticulum-Mitochondria Kissing in Cardiomyocytes: Ca2+, ATP, and Undisclosed Secrets. Frontiers in Cell and Developmental Biology 8:532
Eisner DA, Caldwell JL, Kistamás K, Trafford AW (2017) Calcium and excitation-contraction coupling in the heart. Circ Res 121:181–195
Andrienko TN, Picht E, Bers DM (2009) Mitochondrial free calcium regulation during sarcoplasmic reticulum calcium release in rat cardiac myocytes. J Mol Cell Cardiol 46:1027–1036
Okatan EN, Durak AT, Turan B (2016) Electrophysiological basis of metabolic-syndrome-induced cardiac dysfunction. Can J Physiol Pharmacol 94:1064–1073
Wang X, Han X, Li M, Han Y, Zhang Y, Zhao S, Li Y (2018) Ticagrelor protects against AngII-induced endothelial dysfunction by alleviating endoplasmic reticulum stress. Microvasc Res 119:98–104. https://doi.org/10.1016/j.mvr.2018.05.006
Afzal M, Kren BT, Naveed AK, Trembley JH, Ahmed K (2020) Protein kinase CK2 impact on intracellular calcium homeostasis in prostate cancer. Molecular and Cellular Biochemistry. https://doi.org/10.1007/s11010-020-03752-4
Qaiser F, Trembley JH, Kren BT, Wu JJ, Naveed AK, Ahmed K (2014) Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function. J Cell Biochem 115:2103–2115
Schmidt O, Harbauer AB, Rao S, Eyrich B, Zahedi RP, Stojanovski D, Schönfisch B, Guiard B, Sickmann A, Pfanner N (2011) Regulation of mitochondrial protein import by cytosolic kinases. Cell 144:227–239
Szymański J, Janikiewicz J, Michalska B, Patalas-Krawczyk P, Perrone M, Ziółkowski W, Duszyński J, Pinton P, Dobrzyń A, Więckowski MR (2017) Interaction of mitochondria with the endoplasmic reticulum and plasma membrane in calcium homeostasis, lipid trafficking and mitochondrial structure. Int J Mol Sci 18:1576
Makrecka-Kuka M, Liepinsh E, Murray AJ, Lemieux H, Dambrova M, Tepp K, Puurand M, Kaambre T, Han WH, de Goede P, O’Brien KA, Turan B, Tuncay E, Olgar Y, Rolo AP, Palmeira CM, Boardman NT, Wust RCI, Larsen TS (2019) Altered mitochondrial metabolism in the insulin-resistant heart. Acta Physiol (Oxf). https://doi.org/10.1111/apha.13430
Halim H, Pinkaew D, Chunhacha P, Sinthujaroen P, Thiagarajan P, Fujise K (2019) Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel. PloS one 14:e0218934
Kang M, Shao S, Zhang Y, Liang X, Zhang K, Li G (2019) Beneficial Effects of Ticagrelor on Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Apoptosis in Human Umbilical Vein Endothelial Cells. Med Sci Monit 25:9811
Fauconnier J, Lanner JT, Zhang SJ, Tavi P, Bruton JD, Katz A, Westerblad H (2005) Insulin and inositol 1,4,5-trisphosphate trigger abnormal cytosolic Ca2+ transients and reveal mitochondrial Ca2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes 54:2375–2381. https://doi.org/10.2337/diabetes.54.8.2375
Yaras N, Ugur M, Ozdemir S, Gurdal H, Purali N, Lacampagne A, Vassort G, Turan B (2005) Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes 54:3082–3088
Tuncay E, Turan B (2016) Intracellular Zn(2+) Increase in Cardiomyocytes Induces both Electrical and Mechanical Dysfunction in Heart via Endogenous Generation of Reactive Nitrogen Species. Biol Trace Elem Res 169:294–302. https://doi.org/10.1007/s12011-015-0423-3
Sharmin E, Dewan JF, Ahsan SA, Hoque H, Ahmed SF, Sultan MAU, Bhuiyan HA, Bhadra S, Barua C (2016) Effect of Ticagrerol versus Clopidogrel on Oxidative Stress Bio-markers in Patients with Chronic Stable Angina after Percutaneous Coronary Intervention. Univ Heart J 12:26–30
Navarese EP, Buffon A, Kozinski M, Obonska K, Rychter M, Kunadian V, Austin D, De Servi S, Sukiennik A, Kubica J (2013) A critical overview on ticagrelor in acute coronary syndromes. QJM 106:105–115
Tatarunas V, Kupstyte-Kristapone N, Zvikas V, Jakstas V, Zaliunas R, Lesauskaite V (2020) Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome. Sci Rep 10:3175. https://doi.org/10.1038/s41598-020-59663-3
Ait-Mokhtar O, Bonello L, Benamara S, Paganelli F (2012) High on Treatment Platelet Reactivity. Heart Lung Circ 21:12–21. https://doi.org/10.1016/j.hlc.2011.08.069
Bonello L, Laine M, Kipson N, Mancini J, Helal O, Fromonot J, Gariboldi V, Condo J, Thuny F, Frere C (2014) Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. J Am Coll Cardiol 63:872–877
Jeong HS, Hong SJ, Cho S-A, Kim J-H, Cho JY, Lee SH, Joo HJ, Park JH, Yu CW, Lim D-S (2017) JACC 10:1646–1658
Chang Y-C, Hee S-W, Hsieh M-L, Jeng Y-M, Chuang L-M (2015) The role of organelle stresses in diabetes mellitus and obesity: implication for treatment. Analytical cellular pathology. https://doi.org/10.1155/2015/972891
Hasnain SZ, Prins JB, McGuckin MA (2016) Oxidative and endoplasmic reticulum stress in b-cell dysfunction in diabetes. J Mol Endocrinol 56:33–54
Tubbs E, Theurey P, Vial G, Bendridi N, Bravard A, Chauvin M-A, Ji-Cao J, Zoulim F, Bartosch B, Ovize M (2014) Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes 63:3279–3294
Valentina C, Matteucci M, Pasanisi EM, Papa A, Lucio B, Fritsche-Danielson R, Vincenzo L (2020) Ticagrelor Enhances Release of Anti-Hypoxic Cardiac Progenitor Cell-Derived Exosomes Through Increasing Cell Proliferation In Vitro. Scientific Reports (Nature Publisher Group). https://doi.org/10.1038/s41598-020-59225-7
Acknowledgements
This work was supported by Grants (No. SBAG216S979) from The Scientific and Technological Research Council of Turkey.
Author information
Authors and Affiliations
Contributions
B.T. designed and supervised the research and provided the final approval of the version to be published; S.O. supervised the research and contributed to the editing of the manuscript; Y.O., E.T., A.D, and S.D. contributed and performed the experiments and analyzed the data; D.B. performed all light and electron microscopic analysis. All authors discussed the results and commented on the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Informed consent
All experimental protocols were approved by the Institutional Animal Care and Use Committee of the Ankara University. All animals received human care under an institutionally approved experimental animal protocol with ethical license in Turkey.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Olgar, Y., Durak, A., Degirmenci, S. et al. Ticagrelor alleviates high-carbohydrate intake induced altered electrical activity of ventricular cardiomyocytes by regulating sarcoplasmic reticulum–mitochondria miscommunication. Mol Cell Biochem 476, 3827–3844 (2021). https://doi.org/10.1007/s11010-021-04205-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-021-04205-2